Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
After 6 weeks of maximal Ranolazine therapy, tissue hemoglobin desaturation kinetics will change compared to placebo in patients with chronic angina and peripheral arterial disease.
Epistemonikos ID: 5432d8c19a0f00d317dc03b2b4cd2683ef3d9c35
First added on: May 05, 2024